News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Alessandro Villa: The management of oral toxicities secondary to targeted therapy
Photo of Alessandro Villa from southfloridahospitalnews.com
Aug 1, 2024, 15:23

Alessandro Villa: The management of oral toxicities secondary to targeted therapy

shared a post on LinkedIn about a recent paper titled “MASCC/ISOO Clinical Practice Statement: Management of oral complications of targeted therapy” published in Supportive Care in Cancer.

Authors: Alessandro Villa, Joel B. Epstein, Noam Yarom, Catherine Hong, Caroline Fulop, Paolo Bossi, Sharon Elad.

“I’m excited to share our latest publication on the management of oral toxicities secondary to targeted therapy in patients with cancer.

You can read it here.”

Source:

Alessandro Villa Baptist health cancer Caroline Fulop Catherine Hong International Society Oral Oncology ISOO Joel B. Epstein MASCC Noam Yarom OncoDaily Oncology oral complications Oral Medicine Oral Oncology Paolo Bossi Sharon Elad Supportive Care in Cancer targeted therapy The Multinational Association of Supportive Care in Cancer
Special Coverage
Blog
Nov 13, 2024, 11:34
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center